OpenAI's Leadership Shakes Up Amid Executive Departures and Medical Leave

OpenAI's Fidji Simo, CEO of AGI deployment, is taking a medical leave due to a neuroimmune condition. COO Brad Lightcap is shifting to a new role, including leading 'special projects', and CMO Kate Rouch will step down for cancer recovery.

OpenAI is undergoing significant leadership changes with several top executives taking medical leave or stepping down. Fidji Simo, the CEO of AGI deployment, informed staff that she will be taking a medical leave of absence due to a neuroimmune condition [doc2 doc4].

In her absence, President Greg Brockman will oversee product, including the company's super app efforts .

On the executive front, COO Brad Lightcap will shift to a new role, specifically taking on 'special projects' . CMO Kate Rouch has decided to step down to focus on cancer recovery, and her timeline for return will depend on her health .

The leadership changes come as OpenAI is preparing for an expected IPO and is undergoing major restructuring.